US 11382955
Long-acting VEGF inhibitors for intraocular neovascularization
granted A61KA61K38/179A61K39/001109
Quick answer
US patent 11382955 (Long-acting VEGF inhibitors for intraocular neovascularization) held by The Regents of the University of California expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K38/179, A61K39/001109, A61K9/0019, A61K9/0048